Nanotechnology Now

Our NanoNews Digest Sponsors
Heifer International



Home > Press > Public Debate: Nanomedicine… hype? Or a real revolution in healthcare?

Abstract:
Institute of Nanotechnology, a global leader in nanotechnology information services is organising a public engagement evening ‘Nanomedicine…hype? Or a real revolution in healthcare?' on the 28th of November at the Royal College of Surgeons of London. This free event offers an opportunity to the general public to share their thoughts with industrial leaders, nanotechnologists and politicians.

Public Debate: Nanomedicine… hype? Or a real revolution in healthcare?

London, UK | Posted on September 4th, 2007

Nanotechnology has found applications in almost every industrial sector from golf balls to cancer treatment, scratch-free paints to dirt repellent trousers, and bicycles to supercomputers. Of all the potential applications of nanotechnology, nanomedicine - the application of nanotechnology to healthcare is poised to revolutionise medical treatments and therapies in areas such as imaging, faster diagnosis, drug delivery and tissue regeneration, as well as the development of new medical products. Analysts predict the demand for nanomedical products in US alone to reach $53 billion by 2011.

But while the potential benefits of nanomedicine are widely lauded, is there a downside to any of this? What about the risks of nanotechnology? Are there adequate controls in place? Regulation? Ethical issues? Can we afford it? These are all perfectly valid questions and if nanomedicine is to be successful they must be clearly and transparently addressed.

The debate aims to bring together the general public along with nanotechnologists, researchers, clinicians, industry, policy makers, regulators, trade associations, non-governmental organisations, media and other stakeholders under one roof to discuss and debate the potential applications of nanomedicine as well as the social, ethical and environmental risks.

Chaired by Geoff Watts, eminent writer and broadcaster on science and medicine and currently the presenter of the BBC Radio 4 ‘Leading Edge' programme, the panel members who will lead the discussions include Dr. Doug Naysmith, MP, Bristol North West, Dr. Leonard Fass, Director of Academic Relations, GE Healthcare, Mr. Michael Lussier, General Manager, Volcano Corporation, Prof. Shervanthi Homer-Vanniasinkam, Consultant Vascular Surgeon, Leeds General Infirmary; Clinical Sub-Dean, Leeds University Medical School and Dr. Marisa Papaluca Amati, Deputy Head of Sector, European Medicines Agency (EMEA)

In the interest of openness and public engagement this panel discussion and public debate, which will be held at the Royal College of Surgeons from 18h30 - 20h30 on 28 November 2007, is open to all and is free. Places are limited and, therefore, early registration is recommended. For more information and registration, visit: http://www.nano.org.uk/events/ionevents.htm or contact Tiju Joseph, , 0141 330 8734

The event is organised in conjunction with the ‘Investing in Medical Nanotechnologies II', conference and exhibition to be held at the Royal College of Surgeons on the 28th and 29th November 2007 - http://nanomednet.org/conference07

####

About Institute of Nanotechnology
The Institute of Nanotechnology is a charitable organization created to foster, develop and promote all aspects of science and technology in those domains where dimensions and tolerances in the range of 0.1 nm to 100nm play a critical role.

For more information, please click here

Contacts:
Tiju Joseph

Copyright © Institute of Nanotechnology

If you have a comment, please Contact us.

Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.

Bookmark:
Delicious Digg Newsvine Google Yahoo Reddit Magnoliacom Furl Facebook

Related News Press

Nanomedicine

Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024

NYU Abu Dhabi researchers develop novel covalent organic frameworks for precise cancer treatment delivery: NYU Abu Dhabi researchers develop novel covalent organic frameworks for precise cancer treatment delivery September 13th, 2024

Unveiling the power of hot carriers in plasmonic nanostructures August 16th, 2024

Nanobody inhibits metastasis of breast tumor cells to lung in mice: “In the present study we describe the development of an inhibitory nanobody directed against an extracellular epitope present in the native V-ATPase c subunit.” August 16th, 2024

Announcements

Nanotechnology: Flexible biosensors with modular design November 8th, 2024

Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024

Turning up the signal November 8th, 2024

Nanofibrous metal oxide semiconductor for sensory face November 8th, 2024

Events/Classes

A New Blue: Mysterious origin of the ribbontail ray’s electric blue spots revealed July 5th, 2024

Researchers demonstrate co-propagation of quantum and classical signals: Study shows that quantum encryption can be implemented in existing fiber networks January 20th, 2023

CEA & Partners Present ‘Powerful Step Towards Industrialization’ Of Linear Si Quantum Dot Arrays Using FDSOI Material at VLSI Symposium: Invited paper reports 3-step characterization chain and resulting methodologies and metrics that accelerate learning, provide data on device pe June 17th, 2022

June Conference in Grenoble, France, to Explore Pathways to 6G Applications, Including ‘Internet of Senses’, Sustainability, Extended Reality & Digital Twin of Physical World: Organized by CEA-Leti, the Joint EuCNC and 6G Summit Sees Telecom Sector as an ‘Enabler for a Sustainabl June 1st, 2022

NanoNews-Digest
The latest news from around the world, FREE




  Premium Products
NanoNews-Custom
Only the news you want to read!
 Learn More
NanoStrategies
Full-service, expert consulting
 Learn More











ASP
Nanotechnology Now Featured Books




NNN

The Hunger Project